信达生物(01801)授出402.37万份购股权及2312.83万股受限制股份

智通财经
29 Mar

智通财经APP讯,信达生物(01801)发布公告,于2025年3月28日,公司根据2024年股份计划的条款向49名承授人(包括董事)授出402.37万份购股权,惟须待承授人接纳。

于2025年3月28日,公司根据2024年股份计划的条款向1261名承授人(包括董事)授出2312.83万股受限制股份,惟须待承授人接纳。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10